Missed #ACC2026?
All sessions are now available to watch.
They cover how antibacterial R&D moves from early research to development, and where the gaps are.
▶️Watch here: acc-conference.com#agenda
We heard you 👀 With the long weekend coming up, many couldn’t join Entrepreneurs Club #6 — so we’ve moved it!
📅 May 28 | 🕔5pm CEST
Join us for “What does it take to be an entrepreneur?” !
Save your spot ➡️ www.eventbrite.ch/e/entreprene...
#EntrepreneursClub #StartupLife
If you're at ESCMID Global, please come meet my colleague Shirine at booth G71 to learn more about #REVIVE and share your ideas how we can continue to support the antimicrobial R&D community.
revive.gardp.org
Did you know?
🧵 1/3
🆕A newly published piece in @natureportfolio.nature.com examines the NeoSep1 trial expansion led by GARDP
Aiming to enrol 3,000+ newborns across Africa and Asia, the trial will generate evidence that clinicians can use immediately, leading to better outcomes for newborns.
🔗 bit.ly/4vbZ4LY
A great milestone with real public health impact! 🎉
Our education and outreach programme for antimicrobial researchers would be nothing without the generous, voluntary contributions of countless leading experts.
Thank you!
#knowledgesharing #AMR
🌍🔬 In 2025, REVIVE welcomed 17 new experts to its global network supporting antimicrobial R&D.
Together with over 200 specialists across discovery, development and access, they help accelerate innovation against drug-resistant infections.
#AMR #AntibioticInnovation #GlobalHealth #REVIVE
📢 NEWS: Kenya joins GARDP’s NeoSep1 Part 2 trial on #NeonatalSepsis.
The trial has started enrolling newborn babies with sepsis at Kilifi County Hospital (Kilifi) Coast General Teaching & Referral Hospital (Mombasa) and Mbagathi Hospital (Nairobi).
🌍🏆 Dr Manica Balasegaram has been named one of TIME’s 100 most influential people in health for advancing and expanding access to new antibiotic treatments so as to tackle antimicrobial resistance.
🔗 Read the TIME feature: time.com/collections/...
#TIME100
🔴💥 Session Seven moment
“From erections to resurrection — not womb to tomb.”
With that striking opening, Dr Teodora Elvira C. Wi reframes the conversation on STIs, maternal infections and neonatal sepsis, and why early action matters.
🎦Watch the rest of the session LIVE: bit.ly/3LVHIkF
#ACC2026
Just my thoughts: Research is not only needed for life-threatening conditions but also for less critical ones. Carrying and feeding one or more children takes years of our lives, and even non-critical conditions cause suffering over such a timeframe. Would we ask men to just accept that?
Excited to learn more in this session! More research including pregnant and breastfeeding women is urgently needed.
“No one should die from TB.”
Dr Wanatpreeya Phongsamart emphasized that equity in TB care means prioritizing pregnant women and children, who face high mortality yet remain underrepresented in research and trials🤱👶
💭🔗 Join us: bit.ly/3NTXxZG
#ACC2026
3⃣🚀Session Three has just started at #ACC2026
The focus turns to preclinical antimicrobial development, with talks exploring lysin biotherapeutics, anti-virulence approaches and new adjunct therapies to tackle drug-resistant infections.
🎥 Join us now: portalapp.bsac.eventsair.com/VirtualAtten...
🔴 Keynote now live at #ACC2026
Topic: Optimising multinational clinical trials with antimicrobials and the critical role of clinical trial networks 🧬🌍
Featuring Prof David Paterson, National University of Singapore and ADVANCE-ID.
🔗 bit.ly/4rmSteA
@advance-id.bsky.social
📣ACC2026 kicks off tomorrow!
Join a global, online and open-access conference our antimicrobial chemotherapy, AMR and the future of antibiotic innovation.
🗓️ 4–5 Feb 2026 | 🌍 Online
🔗 Last chance to register: https://eventsair.pulse.ly/35puv6u0m6
#ACC2026
Visit CARB-X’s virtual booth at ACC 2026 from Feb. 4-5 to learn more about our work! This free, virtual event is RCPath CPD approved for 8 credits. Earn continuing education credits and learn about antimicrobial drug discovery and clinical trial networks. #IDSky 🧪
🔗 Register: bit.ly/4t29ooI
Let's try again to tag those organizations 🫠
@gardp.bsky.social
@bsacandjac.bsky.social
@advance-id.bsky.social
@camo-net.bsky.social
@carb-x.bsky.social
@eupohamr.bsky.social
@incate.bsky.social
Visit the virtual exhibition center at #ACC2026 & learn more about key organizations in #AMR R&D:
✅@gardp.bsky.social
✅@bsacandjac.bsky.social
✅@advance-id.bsky.social
✅Mahidol University
✅@camo-net.bsky.social
✅@carb-x.bsky.social
✅CF AMR Syndicate
✅@eupohamr.bsky.social
✅@incate.bsky.social
✅PACE
The open-access Antimicrobial Chemotherapy Conference is more than “just” interesting presentations and discussions by leading experts!
You can also explore and meet key organizations in #antimicrobialR&D!
⏩Full list in next post
📅4&5 Feb
✍️Register: acc-conference.com
Explore the conference brochure here and get to know our speakers: shorturl.at/MfwWQ
Really, each year I am amazed and grateful to see that so many leading experts donate their time to our open-access conference! #knowledgesharing
If you haven't registered for our open-access virtual Antimicrobial Chemotherapy Conference next week,
You. Are. Missing. Out!
The speaker line-up is just top-notch! I mean, just look at this: acc-conference.com 🤩
#AMR #antimicrobialR&D #openaccess #ACC2026
A little sad that I have totally missed the first ever #WorldPPHDay but great to see that there is action!
I was very unlucky to almost "manage" to die from PPH in a rich country like Switzerland, but I was SO lucky to have access to all care, tools, knowledge and medicines needed to keep me alive.
This post is brought to you by: BLOOD 🩸
As I am nearing the 4th anniversary of almost dying from #postpartumhaemorrhage, I am thrilled to see that blood donation criteria in Switzerland will change from 1 Feb, allowing more people to become donors. I hope to be one of them soon!
shorturl.at/KstxJ
🚀 ACC2026 is coming up soon
This free, global, online conference brings together leading minds and experts to explore what’s next for antimicrobial chemotherapy.
Co-organized by GARDP and BSAC
📅 4–5 Feb 2026 |🌍 Online
🔗 Register now: bit.ly/4pSEdt7
@bsacandjac.bsky.social @advance-id.bsky.social
📢 Exciting news!
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
💻📱 AntibioticDB Relaunched: New Functions, More Compounds, & Richer Data to Accelerate Antibiotic Discovery
💊 GARDP’s upgraded open-access database is a go-to tool for researchers, developers & innovators in the antibiotic space.
Start exploring🔗 revive.gardp.org/antibioticdb/
#REVIVE
